Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
CD4+CD25+ T cells play a central role in the suppression of autoimmunity and inflammation, making their in vivo expansion a highly attractive therapeutic target. By phenotyping with a novel rat CTL antigen‐4 (CTLA‐4)‐specific monoclonal antibody (mAb) and functional in vitro assays, we here first establish that rat CD4+CD25+ T cells correspond to the regulatory T cells (T reg cells) described in mice and humans: they constitutively express CTLA‐4, produce IL‐10 but not IL‐2, and are able to suppress the proliferation of costimulated CD25‐negative indicator cells. Furthermore, we show that rat T reg cells respond less well than CD25– T cells to conventional costimulation, but are readily expanded in vitro with "superagonistic" CD28‐specific mAb which are potent mitogens for all T cells without the need for TCR engagement. In vivo, functional T reg cells are preferentially expanded by CD28 stimulation over other T cell subsets, leading to a 20‐fold increase within 3 days in response to a single antibody dose. These data suggest that CD28‐driven activation of T reg cells may be highly effective in the treatment of inflammatory and autoimmune diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodent models, treatment with CD28 superagonists orthologous to TGN1412 stimulated the release of anti-inflammatory cytokines and the expansion of regulatory T-cells believed to counter autoimmune responses (Rodríguez-Palmero et al., 1999;Lin and Hünig, 2003;Beyersdorf et al., 2005).”
From Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 + effector memory T‐cells (2010) · cites this paper as Lin and Hünig, 2003
In the citing paper
“injection of such 'superagonistic (SA)' mAbs (also called CD28 superagonists, CD28SA) into rats resulted in a preferential activation and expansion of a subset of CD4 T cells called regulatory T cells (Treg cells) [2]”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [2]
In the citing paper
“Rapid expansion of regulatory T cells (here defined by FACS analyses as CD4+ CD25+ cells among splenic lymphocytes) in rats after a single injection of the rat-specific CD28SA JJ316.Modified from Ref.[2].”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [2]
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri821 · Cited by 2,110
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Research works printed but not linked: 4
- 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T · doi:10.1002/1521-4141(200106)31:6<1637::aid-immu1637>3.0.co;2-t
- 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P · DOI · Paper page
- 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M · DOI · Paper page
- 10.1002/1521-4141(200003)30:3<876::AID-IMMU876>3.0.CO;2-M · doi:10.1002/1521-4141(200003)30:3<876::aid-immu876>3.0.co;2-m
Cited by
Items 101–184 of 184
Baron, K. J., & Turnquist, H. R. (2023) · Organogenesis · doi:10.1080/15476278.2022.2164159 · Cited by 27
Superagonistic CD28 Antibody Induces Donor-Specific Tolerance in Rat Renal Allografts
Azuma, H., Isaka, Y., Li, X., Hünig, T., Sakamoto, T., Nohmi, H., Takabatake, Y., Mizui, M., Kitazawa, Y., Ichimaru, N., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02358.x · Cited by 28
Self-citationDendritic cell–regulatory T‐cell interactions control self‐directed immunity
Lange, C. M., Dürr, M., Doster, H., Melms, A., & Bischof, F. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100088 · Cited by 31
Tamura, C., Nakazawa, M., Kasahara, M., Hotta, C., Yoshinari, M., Sato, F., & Minami, M. (2006) · Autoimmunity · doi:10.1080/08916930600833390 · Cited by 26
Large‐scale expansion of rat CD4+ CD25+ Treg cells in the absence of T‐cell receptor stimulation
Beyersdorf, N., Balbach, K., Hünig, T., & Kerkau, T. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02455.x · Cited by 32
Self-citationThe role of the FOXP3 transcription factor in the immune regulation of allergic asthma
Schmidt‐Weber, C. B., & Blaser, K. (2005) · Current Allergy and Asthma Reports · doi:10.1007/s11882-005-0006-z · Cited by 29
Kitazawa, Y., Fujino, M., Sakai, T., Azuma, H., Kimura, H., Isaka, Y., Takahara, S., Hünig, T., Abe, R., & Li, X. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.01.004 · Cited by 28
Self-citationImmunotherapy for Tuberculosis
Barnes, P. F. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2305001 · Cited by 26
CD28: A New Drug Target for Immune Disease
Xia, S., Chen, Q., & Niu, B. (2019) · Current Drug Targets · doi:10.2174/1389450120666191114102830 · Cited by 27
The Path to Reactivation of Antitumor Immunity and Checkpoint Immunotherapy
Kim, H. J., & Cantor, H. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0153 · Cited by 29
Hoen, E. N. M. N., Wagenaar-Hilbers, J. P. A., Boot, E. P. J., Lin, C., Arkesteijn, G. J. A., van Eden, W., Taams, L. S., & Wauben, M. H. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324725 · Cited by 28
Self-citationRapid recovery from T lymphopenia by CD28 superagonist therapy
Elflein, K., Rodriguez-Palmero, M., Kerkau, T., & Hünig, T. (2003) · Blood · doi:10.1182/blood-2002-11-3586 · Cited by 25
Self-citationCD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation
Hünig, T., Lühder, F., Elflein, K., Gogishvili, T., Fröhlich, M., Guler, R., Cutler, A. J., & Brombacher, F. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0156-z · Cited by 30
Self-citationLiu, W., Li, W., Cheng, G., & Bao-guo, Z. (2006) · Autoimmunity · doi:10.1080/08916930600758035 · Cited by 24
Xia, G., Kovochich, M., Truitt, R. L., & Johnson, B. D. (2004) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2004.07.004 · Cited by 26
Farzaneh, L., Kasahara, N., & Farzaneh, F. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0189-8 · Cited by 23
Urakami, H., Ostanin, D. V., Hünig, T., & Grisham, M. B. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.042 · Cited by 24
Self-citationCostimulation and Autoimmune Diabetes in BB Rats
Beaudette-Zlatanova, B. C., Whalen, B. J., Zipris, D., Yagita∥, H., Rozing, J., Groen, H., Benjamin, C. D., Hünig, T., Drexhage, H. A., Ansari, M. J., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01227.x · Cited by 25
Self-citationPaterka, M., Voß, J. O., Werr, J., Reuter, E., Heinrich, S., Leuenberger, T., Herz, J., Radbruch, H., Bopp, T., Siffrin, V., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.09.008 · Cited by 25
Regulatory T cells in ischemic cardiovascular injury and repair
Zhuang, R., & Feinberg, M. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.08.004 · Cited by 21
Langenhorst, D., Gogishvili, T., Ribechini, E., Kneitz, S., McPherson, K., Lutz, M. B., & Hünig, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050080 · Cited by 19
Self-citationWin, S. J., Kühl, A. A., Sparwasser, T. D., Hünig, T., & Kamradt, T. (2015) · European Journal of Immunology · doi:10.1002/eji.201546104 · Cited by 22
Self-citationCD28 between tolerance and autoimmunity: the side effects of animal models
Porciello, N., Kunkl, M., & Tuosto, L. (2018) · F1000Research · doi:10.12688/f1000research.14046.1 · Cited by 20
New insights into the mechanisms of allergen-specific immunotherapy
Schmidt‐Weber, C. B., & Blaser, K. (2005) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000191237.43502.d7 · Cited by 24
CTLA-4 Is Important in Maintaining Long-Term Survival of Cardiac Allografts
Chandraker, A. K., Huurman, V. A. L., Hallett, K. M., Yuan, X., Tector, A. J., Park, C. H., Lu, E., Zavazava, N., & Oaks, M. K. (2005) · Transplantation · doi:10.1097/01.tp.0000158275.56248.f8 · Cited by 20
Kenter, M. J. H., & Cohen, A. F. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12605 · Cited by 17
Thoreau, F., & Chudasama, V. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00082a · Cited by 18
Copsel, S. N., Wolf, D., Komanduri, K. V., & Levy, R. B. (2019) · Haematologica · doi:10.3324/haematol.2018.198838 · Cited by 19
Medina, M. Á., Couturier, J. P., Feske, M. L., Mahne, A. E., Turner, M. A., Yu, X., Kozinetz, C. A., Orozco, A. F., Hutchison, A. T., Savidge, T., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0511264 · Cited by 20
Regulatory T cells: magic bullets for immunotherapy?
Frey, O., & Bräuer, R. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0008-0 · Cited by 17
Singh, M., Basu, S., Camell, C. D., Couturier, J. P., Nudelman, R. J., Medina, M. Á., Rodgers, J. R., & Lewis, D. E. (2008) · European Journal of Immunology · doi:10.1002/eji.200737929 · Cited by 17
Regulatory T Cell-Mediated Tissue Repair
Hong, J., & Kim, B.-S. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-0445-3_14 · Cited by 16
Treg cells as a protective factor for Hashimoto`s thyroiditis: a Mendelian randomization study
Guo, J., Si, G., & Si, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1347695 · Cited by 18
Chen, F., Fan, C., Gu, X., Zhang, H., Liu, Q., Gao, X., Lu, J., He, B., & Lai, X. (2015) · Medical Science Monitor · doi:10.12659/msm.893791 · Cited by 12
Targeting Treg Cells In Situ: Emerging Expansion Strategies for (CD4+CD25+) Regulatory T Cells
Shatry, A. M., Chirinos, J., Gorin, M. A., Jones, M., & Levy, R. B. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.06.009 · Cited by 13
Miyasato, K., Takabatake, Y., Kaimori, J., Kimura, T., Kitamura, H., Kawachi, H., Li, X., Hünig, T., Takahara, S., Rakugi, H., et al. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0370-4 · Cited by 14
Self-citationPrinz, I., & Koenecke, C. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0172-3 · Cited by 11
Stabilizing Human Regulatory T Cells for Tolerance Inducing Immunotherapy
He, X., Koenen, H. J. P. M., Slaats, J., & Joosten, I. (2017) · Immunotherapy · doi:10.2217/imt-2017-0017 · Cited by 13
Gladow, N., Hollmann, C., Ramos, G. C., Frantz, S., Kerkau, T., Beyersdorf, N., & Hofmann, U. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227734 · Cited by 12
Human-like Response of Pig T Cells to Superagonistic Anti-CD28 Monoclonal Antibodies
Uehlein, S., Ding, X., Flößer, J., Schmidt, S., Steitz, J., Bille, M., Schnitter, F., Baltes, S., Saalmüller, A., Gerner, W., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100174 · Cited by 15
The T cell-selective IL-2 mutant AIC284 mediates protection in a rat model of Multiple Sclerosis
Weishaupt, A., Paulsen, D., Werner, S., Wolf, N., Köllner, G., Rübsamen‐Schaeff, H., Hünig, T., Kerkau, T., & Beyersdorf, N. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.020 · Cited by 12
Self-citationCD 28 signals the differential control of regulatory T cells and effector T cells
Mikami, N., & Sakaguchi, S. (2014) · European Journal of Immunology · doi:10.1002/eji.201444513 · Cited by 13
Control of immune responses by immunoregulatory T cells
Rudge, G., Gleeson, P. A., & van Driel, I. R. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0045-8 · Cited by 9
Khochenkov, D. A. (2008) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747808040028 · Cited by 10
Takabatake, Y., Li, X., Mizui, M., Miyasato, K., Matsui, I., Kawada, N., Imai, E., Hünig, T., Takahara, S., Wada, T., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00229 · Cited by 9
Self-citationNacka-Aleksić, M., Pilipović, I., Stojić-Vukanić, Z., Kosec, D. J., Bufan, B., Vujnović, I., Arsenović-Ranin, N., Dimitrijević, M., & Leposavić, G. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.09.004 · Cited by 8
Beyersdorf, N., Werner, S., Wolf, N., Hünig, T., & Kerkau, T. (2015) · European Journal of Immunology · doi:10.1002/eji.201445317 · Cited by 8
Self-citationT cells stimulatedin vitrohave a suppressive function but do not contain only regulatory T cells
Valencic, E., Piscianz, E., Tommasini, A., & Granzotto, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03502.x · Cited by 9
Langenhorst, D., Tabares, P., Gulde, T., Becklund, B. R., Berr, S., Surh, C. D., Beyersdorf, N., & Hünig, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01985 · Cited by 9
Self-citationCD4+CD25+regulatory T cells: a therapeutic target for liver diseases
Zheng, M., Gu, D.-N., Braddock, M., Leishman, A. J., Jin, C., Wen, J., Gong, Y., & Chen, Y. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.3.313 · Cited by 8
The effects of antibody treatment on regulatory CD4+CD25+ T cells
Yi, H., Zhang, J., & Zhao, Y. L. (2008) · Transplant Immunology · doi:10.1016/j.trim.2007.12.001 · Cited by 7
Superagonistic CD28 Protects against Renal Ischemic Injury by Expansion of Regulatory T-Cell
Liang, Y., Li, Y., Kuang, Q., Ding, X., Wei, Z., & Fang, Y. (2017) · American Journal of Nephrology · doi:10.1159/000470918 · Cited by 7
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapy
Staudt, S., Ziegler-Martin, K., Visekruna, A., Slingerland, J. B., Shouval, R., Hudecek, M., van den Brink, M. R. M., & Luu, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269015 · Cited by 5
Shi, Q., Niu, Y., Cao, H., Zhou, X., Jiang, S., Liu, Z., & Fan, H. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.02.009 · Cited by 5
Transplant Tolerance, Not Only Clonal Deletion
Hall, B. M., Verma, N. D., Tran, G. T., & Hodgkinson, S. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.810798 · Cited by 6
Jacalin Regulates IgA Production by Peripheral Blood Mononuclear Cells
Miyamoto, K., Chiba, T., Shinohara, N., Nagata, Y., Asakawa, N., Kato, S., Mizutani, N., Murata, T., Nomura, S., & Horiuchi, T. (2012) · Immunotherapy · doi:10.2217/imt.12.125 · Cited by 4
Hillebrands, J., Rozing, J., & Visser, J. T. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1090132 · Cited by 5
Azuma, H., Isaka, Y., Nomi, H., Inamoto, T., Li, X., Hőunig, T., Takabatake, Y., Ichimaru, N., Ibuki, N., Matsumoto, K., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3182007b59 · Cited by 3
Roelcke, V. (2022) · Science in Context · doi:10.1017/s0269889723000170 · Cited by 5
Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
Hoffmann, P., Eder, R., Kunz‐Schughart, L. A., Andreesen, R., & Edinger, M. (2004) · Cancer Cell International · doi:10.1186/1475-2867-4-s1-s11 · Cited by 7
Function and Therapeutic Intervention of Regulatory T Cells in Immune Regulation
Liu, Y., Hou, T., & Hao, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104914 · Cited by 2
Reimagining Tuberculosis Treatment: The Promise of Immunotherapy and Drug Repurposing
Shinde, S., Rathod, S., & Chitlange, S. S. (2025) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921381395250614152438 · Cited by 1
Realizing the potential of agonistic antibody immunotherapy
Cragg, M. S., Yu, X., Paluch, C., & Davis, S. J. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01442-2 · Cited by 2
The Role of Biological Agents in Immunotherapy
Abdulkareem, I. H. (2013) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000116 · Cited by 1
Wagner, J., Leicht, S., Hofmann, M., Seifert, F., Gahn, S., Germer, C., Beyersdorf, N., Otto, C., & Klein, I. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152144 · Cited by 1
IgE Inhibitors in Phase 1 and 2 Clinical Studies for Immunological Disorders
Brennan, F. R. (2014) · Wiley eBooks · doi:10.1002/9783527682423.ch36 · Cited by 1
Les cellules T régulatrices (Treg) dans la polyarthrite rhumatoïde
Boissier, M., Assier, É., Biton, J., Denys, A., Falgarone, G., & Bessis, N. (2008) · Revue du Rhumatisme · doi:10.1016/j.rhum.2008.08.002 · Cited by 1
T Cell Inhibitors in Phase 1 and 2 Clinical Studies for Immunological Disorders
Brennan, F. R. (2014) · Wiley eBooks · doi:10.1002/9783527682423.ch32 · Cited by 1
Stem Cell and Biological Interventions to treat Allergic Airway Disease
Kavanagh, H. (2010) · Maynooth University ePrints and eTheses Archive (Maynooth University) · Cited by 1
Exploiting the potential of regulatory T cells in the control of type 1 diabetes
Giarratana, N., Penna, G., Gregori, S., Daniel, K. C., & Adorini, L. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7301-6_6 · Cited by 1
Role of regulatory T cells in immune tolerance
Swee, L. K. (2009) · edoc (University of Basel) · doi:10.5451/unibas-004811234
Unravelling disease mechanisms in juvenile dermatomyositis
Elst, E. F. (2007) · Utrecht University Repository (Utrecht University)
Immunotherapy of rheumatoid arthritis using CD4+CD25+ regulatory T cells
Amelsfort, J. M. R. M.-V., Bijlsma, J. W. J., & Taams, L. S. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7301-6_9
T-cell costimulation blockade in immunologic diseases: role of CD28 family members
Clay, B. S., & Sperling, A. I. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.3.383
Dingermann, T., Winckler, T., & Zündorf, I. (2006) · Pharmazie in unserer Zeit · doi:10.1002/pauz.200690078
Regulatory T cells and immune tolerance after allogeneic hematopoietic stem cell transplantation
Bruinsma, M. (2010) · EUR Research Repository (Erasmus University Rotterdam)
TGN1412: Superagonist Dr. Jekyll and
Criado, G. (2006)
van den Brandt, J., & Reichardt, H. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1090133
Parker, G. A., & Papenfuss, T. L. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47377-2_1
Tuosto, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101843
Tuosto, L. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101843-1
Humanizing a CD28 signaling domain affects CD8 activation, exhaustion and stem-like precursorsPreprint
Brady, A. E., Revu, S. K., Wu, D., Fisk, H., Kone, K., Lydecker, A., Purser, E. J., Smith, N. L., Hilt, Z. T., Woodyear, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.10.642460
Analyse protéomique et interactomique de l'activation des lymphocytes T humains primaires
Nicolas, P. (2021) · theses.fr (ABES) · doi:10.70675/defcbd86z76d7z43bfz9103zb8a743a479f5
Metadata
- Authors
- Lin, C., & Hünig, T.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Hünig, Thomas
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2003-02-17
- Volume
- 33
- Issue
- 3
- Pages
- 626-638
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1992139204
- Cited by
- 184
- References
- 44
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 8 · 2014: 10 · 2013: 6 · 2012: 11
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- regulatory T cells, CD28 costimulation, CTLA-4, CD4+CD25+ T cells, Treg cell expansion, Treg suppressive function, IL-10, autoimmune disease therapy, inflammatory disease therapy, T cell activation
- MeSH terms
- Abatacept, Animals, Antigens, Differentiation, Interleukin-2, Mice, Inbred BALB C, Rats, Inbred Lew, T-Lymphocytes, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Interleukin-10, CD28 Antigens, Immunoconjugates, T-Lymphocytes, Regulatory, Mice, Rats, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.